Emily Bernstein

11PUBLICATIONS
135CO-AUTHORS
Haematological tumoursMolecular targetsMedical biochemistry - amino acids and metabolitesAutoimmunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 18, 2026
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

D Bennett, M Wierdl, S Chakraborty

|Dec 06, 2025
Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia.

Ke Wang, Shayan Saniei, Nikita Poddar

|Oct 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target.

Imène Krossa, Céline Pisibon, Yann Cheli

|Oct 24, 2025
Loss of histone macroH2A1.1 causes kidney abnormalities secondary to a change in nutrient metabolization.

René Winkler, Gemma Comas-Armangué, David Corujo

|Aug 25, 2023
Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1+ PD-1+ CD8 T cells.

Etienne Humblin, Isabel Korpas, Jiahua Lu

Pageof 2